(Alliance News) - London's equities got off to a slow start on Monday, lagging behind more positive trading in Europe and Friday's rally on Wall Street. Read More
(Alliance News) - Fusion Antibodies PLC on Thursday celebrated the launch of a new commercial service from its research and development programme, designed to address mammalian cell surface expression. Read More
(Alliance News) - Fusion Antibodies PLC on Monday said its loss has widened and revenue is down, after the first half of the financial year proved a "challenging period". Read More
(Alliance News) - Fusion Antibodies PLC on Tuesday said it achieved full-year revenue ahead of expectations, due to its transient expression service. Read More
Fusion Antibodies PLC - Belfast-based antibody developer - Submits patent application for its bispecific designs for antigen display. The designs include an antigen part, and a "reporter" part, called a "bispecific". Believes the reporter part will increase the rate of success in the identification of highly potent antibodies from its range of Antibody Discovery technologies. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Fusion Antibodies PLC on Friday said it expects to post double-digit growth in revenue, leading to strong expectations for the current period. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More